ANI Pharmaceuticals, Inc. announced the appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory Affairs, effective January 17, 2017. Dr. Quinn worked most recently with Takeda Pharmaceuticals International as Senior Director, Global Regulatory Affairs/CMC and Head of the Biologics Group.